儿童癌症长期幸存者后续肿瘤的遗传风险
该研究对3006名儿童癌症长期幸存者进行全基因组测序,评估癌症易感基因致病突变与后续肿瘤风险的关系。研究发现5.8%的幸存者携带致病/可能致病突变,且突变与放疗后乳腺癌和肉瘤风险显著增加相关,在未放疗幸存者中与任何后续肿瘤风险增加相关。结论支持所有幸存者接受遗传咨询。
要点
- 5.8%的儿童癌症幸存者携带癌症易感基因致病突变。
- 突变携带者放疗后乳腺癌和肉瘤风险显著增高。
- 未放疗幸存者中突变与任何后续肿瘤风险增高相关。
核心结论
- 儿童癌症幸存者中癌症易感基因致病突变与后续肿瘤风险增加相关,支持对所有幸存者进行遗传咨询。
研究设计与样本
- 回顾性医院队列研究(St Jude Lifetime Cohort),对3006名儿童癌症幸存者进行30倍全基因组测序,中位年龄35.8岁,56%接受放疗。
主要发现
- 在5.8%(95%CI 5.0%至6.7%)的幸存者中识别出175个致病/可能致病突变。
- 放疗幸存者中,突变与乳腺癌(RR 13.9,95%CI 6.0至32.2)和肉瘤(RR 10.6,95%CI 4.3至26.3)风险显著增加相关。
- 未放疗幸存者中,突变与任何后续肿瘤(RR 4.7,95%CI 2.4至9.3)、乳腺癌(RR 7.7,95%CI 2.4至24.4)、非黑色素瘤皮肤癌(RR 11.0,95%CI 2.9至41.4)及两种以上不同组织学后续肿瘤(RR 18.6,95%CI 3.5至99.3)风险增加相关。
临床怎么用
- 建议所有儿童癌症幸存者转诊进行遗传咨询,以考虑临床基因检测。
- 对于未放疗且发生任何后续肿瘤的幸存者,以及放疗野内发生乳腺癌或肉瘤的幸存者,应优先进行基因检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Purpose Childhood cancer survivors are at increased risk of subsequent neoplasms (SNs), but the germline genetic contribution is largely unknown. We assessed the contribution of pathogenic/likely pathogenic (P/LP) mutations in cancer predisposition genes to their SN risk. Patients and Methods Whole-genome sequencing (30-fold) was performed on samples from childhood cancer survivors who were ≥ 5 years since initial cancer diagnosis and participants in the St Jude Lifetime Cohort Study, a retrospective hospital-based study with prospective clinical follow-up. Germline mutations in 60 genes known to be associated with autosomal dominant cancer predisposition syndromes with moderate to high penetrance were classified by their pathogenicity according to the American College of Medical Genetics and Genomics guidelines. Relative rates (RRs) and 95% CIs of SN occurrence by mutation status were estimated using multivariable piecewise exponential regression stratified by radiation exposure. Results Participants were 3,006 survivors (53% male; median age, 35.8 years [range, 7.1 to 69.8 years]; 56% received radiotherapy), 1,120 SNs were diagnosed among 439 survivors (14.6%), and 175 P/LP mutations were identified in 5.8% (95% CI, 5.0% to 6.7%) of survivors. Mutations were associated with significantly increased rates of breast cancer (RR, 13.9; 95% CI, 6.0 to 32.2) and sarcoma (RR, 10.6; 95% CI, 4.3 to 26.3) among irradiated survivors and with increased rates of developing any SN (RR, 4.7; 95% CI, 2.4 to 9.3), breast cancer (RR, 7.7; 95% CI, 2.4 to 24.4), nonmelanoma skin cancer (RR, 11.0; 95% CI, 2.9 to 41.4), and two or more histologically distinct SNs (RR, 18.6; 95% CI, 3.5 to 99.3) among nonirradiated survivors. Conclusion The findings support referral of all survivors for genetic counseling for potential clinical genetic testing, which should be prioritized for nonirradiated survivors with any SN and for those with breast cancer or sarcoma in the field of prior irradiation.
引用
- Wang Z, Wilson CL, Easton J, et al. Genetic Risk for Subsequent Neoplasms Among Long-Term Survivors of Childhood Cancer. J Clin Oncol. 2018. PMID: 29847298. doi:10.1200/JCO.2018.77.8589
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。